Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2022

Rhea-AI Summary

Medifast (NYSE: MED) will announce its fourth quarter and full year financial results on February 21, 2023, after market close. The announcement will be followed by a conference call at 4:30 p.m. ET, featuring CEO Dan Chard and CFO Jim Maloney. Interested parties can listen via the company's website. A telephonic playback will be available from 6:30 p.m. ET on the same day until February 28, 2023. Medifast emphasizes its position as a leader in the $7 billion weight management industry, impacting over 2 million lives through its community of OPTAVIA Coaches.

Positive

• Medifast leads the $7 billion weight management industry in the U.S.
• Company has impacted over 2 million lives through its community outreach.
• Scheduled announcement of financial results shows transparency and ongoing communication with investors.

Negative

• None.

BALTIMORE, Feb. 7, 2023 /PRNewswire/ -- Medifast (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, will announce financial results for the fourth quarter and full year ended December 31, 2022 on Tuesday, February 21, 2023, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer.

The conference call is scheduled to begin at 4:30 p.m. ET on February 21, 2023. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.MedifastInc.com or directly at https://app.webinar.net/L31bk8pkVE4, and will be archived online and available through March 7, 2023. To join via telephone, listeners may dial (855) 560-2579. 

A telephonic playback will be available from 6:30 p.m. ET, February 21, 2023, through February 28, 2023. Participants can dial (877) 344-7529 and enter passcode 3443014 to hear the playback.

About Medifast^®: 
Medifast (NYSE: MED) is the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, which offers scientifically developed products, clinically proven plans and the support of independent OPTAVIA Coaches and a Community to help Customers achieve Lifelong Transformation, One Healthy Habit at a Time®. As the publicly traded market leader by revenue in the U.S. $7 billion weight management industry, the company has impacted more than 2 million lives through its Community of OPTAVIA Coaches, who teach Customers how to develop holistic healthy habits through the proprietary Habits of Health® Transformational System. Medifast was recognized in 2022 as one of America's Best Mid-Sized Companies by Forbes, in 2020 and 2021 as one of FORTUNE's 100 Fastest-Growing Companies and was named to Forbes' 100 Most Trustworthy Companies in America list in 2017. For more information, visit MedifastInc.com or OPTAVIA.com and follow @Medifast on Twitter.

MED-F

View original content to download multimedia:https://www.prnewswire.com/news-releases/medifast-to-announce-financial-results-for-the-fourth-quarter-and-full-year-ended-december-31-2022-301739971.html

SOURCE Medifast

FAQ

When will Medifast announce its financial results for Q4 2022?

Medifast will announce its financial results for the fourth quarter on February 21, 2023.

What time is the Medifast conference call scheduled for?

The Medifast conference call is scheduled to begin at 4:30 p.m. ET on February 21, 2023.

How can I access the Medifast conference call?

The conference call can be accessed via the Investor Relations section of Medifast's website.

What is the significance of Medifast's upcoming financial results announcement?

The announcement is significant as it provides insights into Medifast's financial health and operational performance.

How long will the telephonic playback of the Medifast conference call be available?

The telephonic playback will be available from 6:30 p.m. ET on February 21, 2023, through February 28, 2023.